Relmada Therapeutics, Inc. (RLMD) Balance Sheet
As of 2026-06-30 (10-Q), Relmada Therapeutics, Inc. (RLMD) reported total assets of $219.1M, total liabilities of $12.5M and shareholders' equity of $206.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $11.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RLMDRelmada Therapeutics, Inc.Follow RLMD — free
—
Price chart with a free account
- Market cap
- 348.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2013 Aug 13 | FY2013 Dec 13 | FY2014 Jun 14 | FY2015 Jun 15 | FY2016 Jun 16 | FY2017 Jun 17 | FY2018 Jun 18 | FY2019 Jun 19 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 3.5 | 25.6 | 22.5 | 8.5 | 1.7 | 2.2 | 9.2 | 36.3 | 2.5 | 44.4 | 5.4 | 4.1 | 3.9 | 3.5 | 11.3 | |
| Short-term investments | — | — | — | — | — | — | — | — | 80.2 | 114.6 | 167.5 | 142.9 | 92.2 | 41.1 | 89.5 | 206.4 | |
| Receivables | — | — | — | — | — | — | — | — | — | — | — | 0.5 | — | — | — | 0.0 | |
| Inventory | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current assets | 0.0 | 3.6 | 25.7 | 24.0 | 9.3 | 2.5 | 2.7 | 10.0 | 116.9 | 118.1 | 223.3 | 152.9 | 97.5 | 45.8 | 94.0 | 219.0 | |
| Total assets | 0.0 | 3.6 | 25.8 | 24.4 | 10.2 | 2.8 | 3.0 | 10.2 | 117.1 | 118.2 | 223.3 | 152.9 | 97.6 | 45.8 | 94.0 | 219.1 | |
| Current liabilities | 0.0 | 21.5 | 26.8 | 15.6 | 3.1 | 1.4 | 5.9 | 2.6 | 1.5 | 12.6 | 15.1 | 12.5 | 12.2 | 10.3 | 6.4 | 7.4 | |
| Long-term debt | — | — | — | — | — | — | 2.7 | — | — | — | — | — | — | — | — | — | |
| Short-term debt | — | — | 0.1 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | — | 21.6 | 26.9 | 15.6 | 3.2 | 1.4 | 8.6 | 2.6 | 1.5 | 12.6 | 15.1 | 12.5 | 12.2 | 10.3 | 7.5 | 12.5 | |
| Shareholders' equity | -0.0 | -17.9 | -1.1 | 8.8 | 7.0 | 1.5 | -5.5 | 7.6 | 115.7 | 105.6 | 208.3 | 140.4 | 85.4 | 35.5 | 86.5 | 206.6 |
USD millions · SEC XBRL
Relmada Therapeutics, Inc. — questions
- How much cash does Relmada Therapeutics, Inc. have?
- $11.3M in cash and cash equivalents as of 2026-06-30.
- What are Relmada Therapeutics, Inc.'s total assets?
- $219.1M as of 2026-06-30.
- What is Relmada Therapeutics, Inc.'s shareholders' equity?
- $206.6M as of 2026-06-30.
Every figure on this page comes from Relmada Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.